LUPIN

Lupin share price has seen a 17% YTD decline and an 11% drop in six months, mirroring the broader pharma sector’s struggles. However, Lupin shares have delivered a 24% return over the past year and an impressive 200% surge in two years, making it one of the best-performing pharma stocks.